Presumed tuberculous XXXX : diagnosis, management, and outcome.

@entity1 @entity32 @entity9178 @entity1596 @entity378 @entity4816
PURPOSE: To assess the effectiveness of anti-tuberculous treatment in @entity1 with @entity1596 and either active @entity9178 ( @entity378 ) in a non-endemic community. METHODS: Retrospective study of @entity1 with @entity1596 , non-ocular evidence of latent or active @entity378 and no other identified cause of @entity1596 who underwent a 6-month course of standard anti-tuberculous chemotherapy. Response to treatment was assessed at 6 and 12 months after initiation of treatment. RESULTS: A total of 27 @entity1 were included of whom 59% were female. In all, 19 were Asian, 4 Caucasian, and 4 Black. More than half of @entity1 had a history of contact with another @entity1 treated for @entity378 . @entity32 resolved after chemotherapy in 70.3% of @entity1 , 18.5% had a change in the nature of their @entity32 and 11.1% had no benefit. CONCLUSIONS: There were no @entity1596 features characteristic of @entity378 and a wide range of manifestations was seen ranging from non-granulomatous anterior @entity1596 to occlusive @entity4816 . @entity378 is not endemic in the United Kingdom, therefore consideration of ethnicity, immigration, and history of @entity378 contact remain important to direct investigations. In a @entity1 with @entity1596 and @entity9178 , a full 6-month course of anti-tuberculous chemotherapy is recommended although it may not be curative of the @entity1596 .
